|
|
|
Volumn 25, Issue 1, 1998, Pages 42-59
|
|
Chronic lymphocytic leukemia: Staging and prognostic factors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
B LYMPHOCYTE ANTIGEN;
BASIC FIBROBLAST GROWTH FACTOR;
BETA 2 MICROGLOBULIN;
BUTHIONINE SULFOXIMINE;
CD23 ANTIGEN;
CD5 ANTIGEN;
CHLORAMBUCIL;
COMPLEMENT COMPONENT C3;
CYCLINE;
CYCLOPHOSPHAMIDE;
CYTOKINE;
DAUNORUBICIN;
DOXORUBICIN;
ETACRYNIC ACID;
FAS ANTIGEN;
GLYCOPROTEIN P;
IMMUNOGLOBULIN;
INTERCELLULAR ADHESION MOLECULE 1;
IRINOTECAN;
KI 67 ANTIGEN;
PREDNISONE;
PROTEIN BCL 2;
PROTEIN P53;
RETINOBLASTOMA PROTEIN;
UNINDEXED DRUG;
VALSPODAR;
VERAPAMIL;
VINCRISTINE;
B CELL LEUKEMIA;
CANCER STAGING;
CANCER SURVIVAL;
CHROMOSOME 12;
CHROMOSOME 13Q;
CHROMOSOME DELETION;
CHRONIC LYMPHATIC LEUKEMIA;
HUMAN;
IMMUNOPHENOTYPING;
LYMPHOCYTE PROLIFERATION;
MULTIDRUG RESISTANCE;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
TRISOMY;
BONE MARROW;
CHROMOSOME ABERRATIONS;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
IMMUNOPHENOTYPING;
LEUKEMIA, LYMPHOCYTIC, CHRONIC;
NEOPLASM STAGING;
PROGNOSIS;
|
|
EID: 0031913505
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (159)
|
|
References (168)
|
